This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendOwnershipTrendsBuy This Stock KOOL vs. THMO, KEQU, IVVD, PROC, GUTS, ZJYL, SAVA, PTHL, MDXH, and BYSIShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include ThermoGenesis (THMO), Kewaunee Scientific (KEQU), Invivyd (IVVD), Procaps Group (PROC), Fractyl Health (GUTS), Jin Medical International (ZJYL), Cassava Sciences (SAVA), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), MDxHealth (MDXH), and BeyondSpring (BYSI). Cesca Therapeutics vs. Its Competitors ThermoGenesis Kewaunee Scientific Invivyd Procaps Group Fractyl Health Jin Medical International Cassava Sciences Pheton Holdings Ltd Class A Ordinary Shares MDxHealth BeyondSpring Cesca Therapeutics (NASDAQ:KOOL) and ThermoGenesis (NASDAQ:THMO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has more risk and volatility, KOOL or THMO? Cesca Therapeutics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Does the MarketBeat Community prefer KOOL or THMO? Cesca Therapeutics received 241 more outperform votes than ThermoGenesis when rated by MarketBeat users. Likewise, 70.45% of users gave Cesca Therapeutics an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote. CompanyUnderperformOutperformCesca TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% ThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% Is KOOL or THMO more profitable? ThermoGenesis has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. ThermoGenesis' return on equity of 0.00% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cesca Therapeutics-98.84% -77.30% -37.75% ThermoGenesis N/A N/A N/A Does the media refer more to KOOL or THMO? In the previous week, Cesca Therapeutics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Cesca Therapeutics Neutral ThermoGenesis Neutral Which has higher earnings & valuation, KOOL or THMO? ThermoGenesis has lower revenue, but higher earnings than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCesca Therapeutics$9.67M2.82-$39.72M-$3.60-3.14ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Do institutionals & insiders hold more shares of KOOL or THMO? 3.1% of Cesca Therapeutics shares are owned by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are owned by institutional investors. 68.9% of Cesca Therapeutics shares are owned by insiders. Comparatively, 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryThermoGenesis beats Cesca Therapeutics on 8 of the 12 factors compared between the two stocks. Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KOOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.29M$109.10M$5.54B$8.63BDividend Yield0.50%N/A5.27%4.17%P/E Ratio-3.146.0626.7419.81Price / Sales2.820.50403.88151.24Price / CashN/A45.3038.2534.64Price / Book3.632.817.114.67Net Income-$39.72M$18.75M$3.22B$248.05M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$11.30-1.0%N/A+9.2%$27.29M$9.67M-3.1453THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040KEQUKewaunee Scientific2.3617 of 5 stars$39.49+1.0%N/A-6.9%$112.74M$220.03M6.26890Positive NewsIVVDInvivyd3.772 of 5 stars$0.91-6.5%$5.85+546.1%-49.9%$108.63M$36.69M-0.46100Positive NewsPROCProcaps GroupN/A$0.95-40.3%N/A-63.5%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeGUTSFractyl Health2.309 of 5 stars$2.16-25.0%$11.00+409.3%-63.5%$105.79M$60K-0.18102Positive NewsHigh Trading VolumeZJYLJin Medical InternationalN/A$0.67-1.6%N/A-74.2%$104.92M$23.50M0.00245News CoveragePositive NewsShort Interest ↓Gap UpSAVACassava Sciences4.2717 of 5 stars$2.17+0.9%$54.50+2,411.5%-89.6%$104.83MN/A-1.5730Positive NewsPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$15.75+5.0%N/AN/A$103.67M$448.20K0.0011Positive NewsMDXHMDxHealth3.2693 of 5 stars$2.16-0.9%$6.50+200.9%-28.8%$102.14M$94.51M-1.42300News CoveragePositive NewsShort Interest ↓Gap UpBYSIBeyondSpringN/A$2.51+13.6%N/A+5.7%$101.19M$1.88M0.0080Positive NewsHigh Trading Volume Related Companies and Tools Related Companies THMO Alternatives KEQU Alternatives IVVD Alternatives PROC Alternatives GUTS Alternatives ZJYL Alternatives SAVA Alternatives PTHL Alternatives MDXH Alternatives BYSI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KOOL) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
